tiprankstipranks

Ibrahim B. Dagher Insider Profile

11 Followers
Ibrahim B. Dagher, Chief Medical Officer at Brainstorm Cell Therapeutics, holds 190.00K shares in Brainstorm Cell Therapeutics (Ticker: BCLI). Most recently, Ibrahim B. Dagher Sold $63,000 shares of Brainstorm Cell Therapeutics on Jul 24, 2024 for an estimated value of 22.05K.
tipranks
Ibrahim B. Dagher

Ibrahim B. Dagher
Brainstorm Cell Therapeutics (BCLI)
Chief Medical Officer

Not Ranked
Ibrahim B. Dagher has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$433K
100.00%
A breakdown of Ibrahim B. Dagher's holdings

Insider Roles

Brainstorm Cell Therapeutics
(BCLI)
Chief Medical Officer
Roles that Ibrahim B. Dagher holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Ibrahim B. Dagher

Ibrahim B. Dagher's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Brainstorm Cell Therapeutics
Jul 24, 2024
Chief Medical Officer
Informative Sell
22.05K
$433.20K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 24, 2024
Informative Sell
$22.05K
-
$0.35
List of latest transactions for each holding click on a transaction to see Ibrahim B. Dagher's performance on stock

Ibrahim B. Dagher insider profile FAQ

What is the percentage of profitable transactions made by Ibrahim B. Dagher?
The percentage of profitable transactions made by Ibrahim B. Dagher is ―.
    What is the average return per transaction made by Ibrahim B. Dagher?
    The average return per transaction made by Ibrahim B. Dagher is ―.
      What stocks does Ibrahim B. Dagher hold?
      Ibrahim B. Dagher holds: BCLI stocks.
        What was Ibrahim B. Dagher’s latest transaction?
        Ibrahim B. Dagher latest transaction was an Informative Sell of $22.05K.
          What was Ibrahim B. Dagher's most profitable transaction?
          Ibrahim B. Dagher’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Ibrahim B. Dagher's role in Brainstorm Cell Therapeutics?
            Ibrahim B. Dagher's role in Brainstorm Cell Therapeutics is Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.